MYGN FY 2021 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$487M

FY 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$691M+24.0% YoY

Gross Profit

$493M71.4% margin

Operating Income

-$191M-27.6% margin

Net Income

-$27M-3.9% margin

EPS (Diluted)

$-0.35

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

$600,000

Stock-Based Comp.

$36M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$353M

Stockholders' Equity

$968M

Cash & Equivalents

$258M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$691M	$557M	+24.0%
Gross Profit	$493M	$379M	+30.1%
Operating Income	-$191M	-$195M	+2.2%
Net Income	-$27M	-$224M	+87.8%